Senior Scientist – Stem Cell Gene Editing

Seattle, Washington State
Salary and title commensurate with experience. Excellent benefits and vacation package.
January 26 2017
Position Type
Full Time
Job Type
Senior Scientist

Senior Scientist – Stem Cell Gene Editing

Universal Cells Inc. ( is a Seattle-based biotechnology company that uses its proprietary genome editing technology based on recombinant AAV to produce pluripotent stem cell products that are universally compatible with patients.  We are currently seeking a highly talented and motivated scientist to join our Research and Development team.  The individual will be responsible for developing cell and molecular biology assays for the analysis of gene-edited human embryonic stem cells (hESCs) and human induced pluripotent stem cells (iPSCs).

Major Duties and Responsibilities:

  • Developing, performing, and troubleshooting flow cytometry and qPCR assays.
  • Culturing and genome editing of human pluripotent stem cells.
  • Performing standard molecular biology techniques.
  • Compiling and analyzing data.
  • Summarizing and presenting data in both oral and written formats.


  • A Ph.D. in biochemistry, biological sciences, or a related discipline.
  • Experience with flow cytometry.
  • Experience with quantitative PCR assays.
  • Cell culture experience.  Experience culturing human pluripotent stem cells is preferred.
  • Strong organizational, time management, and problem solving skills
  • Keen attention to details.
  • Ability to work independently.
  • Excellent record-keeping ability.
  • Entrepreneurial spirit.  Willing to work on a small team in an exciting environment to deliver the next generation of stem cell therapy products.

Salary and title commensurate with experience.

In compliance with federal law, all persons hired will be required to verify identity and eligibility to work in the United States and to complete the required employment eligibility verification document form upon hire.

To apply, send CV and cover letter to be considered.